Elekta Funding: How Much Did They Raise & Key Investors

How Much Did Elekta Raise?
Funding & Key Investors

Elekta, a prominent player in the healthcare technology sector, has secured $200M in total capital, with a recent strategic investment of $200M. This significant backing underscores the company's established position and its ongoing contributions to cancer and brain disorder treatment through advanced radiation therapy and radiosurgery solutions.

The company's financial trajectory, marked by this latest infusion, suggests a mature phase of operations, likely focused on scaling existing technologies and expanding market reach. The nature of the recent funding as a 'major strategic investment' indicates a potential for deeper partnerships or accelerated product development.

What is Elekta?

Elekta

Manufacturing

Medical Devices & Equipment

Founded in 1972 and headquartered in Stockholm, Sweden, Elekta is a global leader in providing sophisticated medical equipment and integrated solutions for the treatment of cancer and brain disorders. Their offerings encompass radiation therapy, radiosurgery, and related clinical management systems, designed to enhance patient outcomes and streamline healthcare delivery. Elekta's commitment to innovation in precision radiation medicine positions it as a critical partner for oncology departments worldwide, driving advancements in patient care and therapeutic efficacy.

How much funding has Elekta raised?

Elekta has raised a total of $200M across 1 funding round:

2011

Debt

$200M

Debt (2011): $200M, investors not publicly disclosed

What's next for Elekta?

With a substantial total funding history and a recent strategic investment, Elekta is poised for continued growth and innovation. The company is likely to leverage this capital to further enhance its product portfolio, potentially through research and development into next-generation treatment technologies or by expanding its global footprint. Strategic collaborations may also be a key focus, aiming to integrate Elekta's solutions more deeply into clinical workflows and to address evolving challenges in oncology care. The company's established market presence suggests a strategic direction focused on solidifying its leadership in precision radiation medicine and driving advancements in patient treatment.

See full Elekta company page

See More Financial Insights